Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery Y Zou, J Xie, S Zheng, W Liu, Y Tang, W Tian, X Deng, L Wu, Y Zhang, ... International Journal of Surgery 107, 106936, 2022 | 133 | 2022 |
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer Y Zou, S Zheng, X Xie, F Ye, X Hu, Z Tian, SM Yan, L Yang, Y Kong, ... Nature communications 13 (1), 2672, 2022 | 103 | 2022 |
The single‐cell landscape of intratumoral heterogeneity and the immunosuppressive microenvironment in liver and brain metastases of breast cancer Y Zou, F Ye, Y Kong, X Hu, X Deng, J Xie, C Song, X Ou, S Wu, L Wu, ... Advanced Science 10 (5), 2203699, 2023 | 102 | 2023 |
The role of circular RNA CDR1as/ciRS-7 in regulating tumor microenvironment: a pan-cancer analysis Y Zou, S Zheng, X Deng, A Yang, X Xie, H Tang, X Xie Biomolecules 9 (9), 429, 2019 | 98 | 2019 |
Diagnostic and prognostic value of circular RNA CDR1as/ciRS‐7 for solid tumours: A systematic review and meta‐analysis Y Zou, S Zheng, X Deng, A Yang, Y Kong, M Kohansal, X Hu, X Xie Journal of cellular and molecular medicine 24 (17), 9507-9517, 2020 | 33 | 2020 |
The pan-cancer multi-omics landscape of FOXO family relevant to clinical outcome and drug resistance J Xie, J Zhang, W Tian, Y Zou, Y Tang, S Zheng, CW Wong, X Deng, S Wu, ... International Journal of Molecular Sciences 23 (24), 15647, 2022 | 30 | 2022 |
Advances in artificial intelligence to predict cancer immunotherapy efficacy J Xie, X Luo, X Deng, Y Tang, W Tian, H Cheng, J Zhang, Y Zou, Z Guo, ... Frontiers in immunology 13, 1076883, 2023 | 26 | 2023 |
Circular RNA KIF4A promotes liver metastasis of breast cancer by reprogramming glucose metabolism J Huang, X Deng, X Chen, Z Chang, Q Lu, A Tang, P Liu Journal of Oncology 2022, 2022 | 14 | 2022 |
Nomogram for predicting prognosis of patients with metastatic melanoma after immunotherapy: A Chinese population–based analysis J Zhao, D Li, S Xie, X Deng, X Wen, J Li, Z Wu, X Yang, M Li, Y Tang, ... Frontiers in Immunology 13, 1083840, 2022 | 10 | 2022 |
Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer X Ou, Y Tan, J Xie, J Yuan, X Deng, R Shao, C Song, X Cao, X Xie, R He, ... Drug Resistance Updates 73, 101063, 2024 | 6 | 2024 |
Circular RNA: A promising new star of vaccine J Xie, F Ye, X Deng, Y Tang, JY Liang, X Huang, Y Sun, H Tang, J Lei, ... Journal of Translational Internal Medicine 11 (4), 372-381, 2023 | 6 | 2023 |
Single-cell histone chaperones patterns guide intercellular communication of tumor microenvironment that contribute to breast cancer metastases J Xie, W Deng, X Deng, JY Liang, Y Tang, J Huang, H Tang, Y Zou, ... Cancer Cell International 23 (1), 311, 2023 | 6 | 2023 |
Recent advances in exosome-based immunotherapy applied to cancer J Xie, Z Zheng, L Tuo, X Deng, H Tang, C Peng, Y Zou Frontiers in Immunology 14, 1296857, 2023 | 6 | 2023 |
Novel implication of the basement membrane for breast cancer outcome and immune infiltration W Tian, Y Luo, Y Tang, Y Kong, L Wu, S Zheng, Y Zou, C Zhang, J Xie, ... International Journal of Biological Sciences 19 (5), 1645, 2023 | 6 | 2023 |
Prognosis stratification in breast cancer and characterization of immunosuppressive microenvironment through a pyrimidine metabolism-related signature Y Luo, W Tian, X Lu, C Zhang, J Xie, X Deng, Y Xie, S Yang, W Du, R He, ... Frontiers in immunology 13, 1056680, 2022 | 5 | 2022 |
Multi-omics analyses unravel DNA damage repair-related clusters in breast cancer with experimental validation P Liu, X Deng, H Zhou, J Xie, Y Kong, Y Zou, A Yang, X Li Frontiers in Immunology 14, 1297180, 2023 | 4 | 2023 |
Integrative analysis of KCNK genes and establishment of a specific prognostic signature for breast cancer Y Zou, J Xie, W Tian, L Wu, Y Xie, S Huang, Y Tang, X Deng, H Wu, X Xie Frontiers in Cell and Developmental Biology 10, 839986, 2022 | 4 | 2022 |
Distant lymph node metastases from breast cancer—Is it time to review TNM cancer staging? Y Zou, X Hu, X Deng JAMA Network Open 4 (3), e212026-e212026, 2021 | 4 | 2021 |
Multi‐omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple‐negative breast cancer J Xie, X Deng, Y Xie, H Zhu, P Liu, W Deng, L Ning, Y Tang, Y Sun, ... MedComm 5 (3), e502, 2024 | 2 | 2024 |
The burgeoning importance of PIWI-interacting RNAs in cancer progression X Deng, T Liao, J Xie, D Kang, Y He, Y Sun, Z Wang, Y Jiang, X Miao, ... Science China Life Sciences, 1-10, 2023 | 2 | 2023 |